Musk and Altman trial could reshape Artificial Intelligence governance

Elon Musk’s lawsuit against OpenAI, Sam Altman, Greg Brockman and Microsoft has opened a high-stakes fight over whether a mission-driven Artificial Intelligence lab can lawfully turn into a commercial powerhouse. The case could affect OpenAI’s structure, leadership and future fundraising while setting a precedent for peers such as Anthropic.

United States weighs frontier Artificial Intelligence testing after deregulatory push

The White House is reconsidering its deregulatory stance on frontier Artificial Intelligence as cyber and national security risks become harder to ignore. A more targeted testing regime is emerging, but the balance between security oversight and innovation remains unsettled.

Artificial Intelligence pushes structural biology toward dynamics and protein design

Structural biology is moving beyond static protein structure prediction toward conformational landscape modeling and routine de novo binder design. New generative systems and accessible deployment platforms are making both capabilities more practical for researchers.